Market Research Reports: OTC Retailing

This report will provide subscribers with a comprehensive, accurate assessment of opportunities for growth and the relative importance of alternate retail channels for OTC sales. This report will exclude major drug, food, and mass merchandisers and focus on rapidly growing alternate channels, such as convenience stores, dollar stores, health food stores, the Internet, and warehouse clubs. The study will provide an analysis of:

• Recent growth in share of OTC sales through these channels
• Prevalence of Internet sales for OTCs, and how that has changed recently
• Relative importance of value pricing in these channels
• Private-label presence in these channels
• Role of social media and retention marketing among these retailers
• Relative importance of these channels by various OTC product classes
• Forecasts and expected future trends for sales of OTCs in alternate channels

OTC Retailing 2012: U.S. Alternate Channel Analyses and Opportunities will provide subscribers with insights into retailing opportunities within alternate channels of distribution.

This report will focus on the U.S. OTC market. The category scope will closely mirror Kline’s Nonprescription Drugs USA program, encompassing 36 categories across eight product classes:

• Allergy, asthma, and sinus products
• Cough and cold preparations
• Digestive products
• Feminine products
• Internal analgesics
• Nutritional products
• Topical products
• Other products

The program will analyze alternate purchase channels including convenience stores, direct sales, dollar stores, health food stores, specialty stores, and warehouse clubs, providing detailed examination of the competitive landscape among these channels.

Profiles will also be provided for key retailers, representing a diverse cross section among alternate channel retailers.

This comprehensive report will enable subscribers to exploit business opportunities by illustrating the retailing dynamics in alternate channels in the United States. Specifically, the report will provide subscribers with the following key deliverables:

• Up-to-date primary research with alternate channel retailers and other knowledgeable industry participants
• An objective perspective on future trends and relative importance of alternate retail channels for the OTC industry
• An understanding of the implications of alternate channels by OTC product class
• Identification of growth trends and successful strategies used by OTC players across these channels
• An understanding of why some channels are growing at faster rates than others in terms of OTC sales
• An unbiased appraisal of retail trends based on extensive primary research with retailers, buyers, and marketers
• Forecasts and summary of expected future trends in alternate retail channels

Forecasts in the report will be generated with Kline's FutureView Scenario Forecasting Model. With the enhanced forecasts, subscribers can see how adjustments in the assumptions behind the forecasts can bring about different outcomes.

Kline is unmatched in our ability to gather hard-to-get market and competitive intelligence with a high degree of confidence. Kline’s market analysis approach places the principal emphasis on primary research techniques to ensure that the foundation of business intelligence and insight is accurate, current, and reliable.

During the course of field research, Kline’s professional staff of industry experts will conduct in-depth interviews with a wide range of knowledgeable industry participants and stakeholders including retail executives such as category managers/buyers, store managers, corporate executives, and OTC executives such as category managers, brand managers, marketing, market research, business development, trade relations, and shopper insights.

In addition to primary research, the study will draw upon relevant secondary data, including company filings, trade journals, Internet searches, product literature, price lists, store checks, and other sources. Historical information will be taken from Kline’s Nonprescription Drugs USA annual market analysis.